🧐 ProPicks AI October update is out now! See which stocks made the listPick Stocks with AI

Dollar hits session highs vs. yen after U.S. housing data

Published 04/28/2014, 11:06 AM
Dollar gains ground after upbeat U.S. housing report
EUR/USD
-
GBP/USD
-
USD/JPY
-
USD/CHF
-
AUD/USD
-
USD/CAD
-
NZD/USD
-
DX
-

Investing.com - The dollar rose to session highs against the yen on Monday after a report showed that U.S. pending home sales rose for the first time in nine months in March, indicating that the housing market is picking up.

USD/JPY touched highs of 102.62 and was last up 0.38% to 102.57.

The dollar found support after the National Association of Realtors reported that pending home sales jumped 3.4% last month, easily surpassing expectations for a 1% gain.

Pending home sales for February were revised to a 0.5% drop from a previously reported decline of 0.8%.

On a year-over-year basis, pending home sales were still down 7.9% in March.

The euro trimmed gains, with EUR/USD last trading at 1.3845, down from session highs of 1.3880.

Demand for the euro continued to be underpinned by hopes that the upcoming report on euro zone inflation on Wednesday would show that consumer prices ticked higher this month, easing pressure on the European Central Bank to implement additional monetary policy measures.

Earlier Monday, ECB Governing Council member Christian Noyer said that while the strong euro was weighing on consumer prices the euro area was not at risk of falling into deflation.

Meanwhile, GBP/USD was trading at 1.6808, not far from the four-and-a-half year peaks of 1.6853 struck earlier Monday.

Demand for the pound continued to be underpinned by expectations that the Bank of England could raise interest rates in the early part of next year.

Market participants were looking ahead to preliminary data on U.K. first quarter growth due for release on Tuesday, amid expectations that growth accelerated in the first three months of this year.

Sterling was also boosted by expectations for merger and acquisition inflows after U.S. drugs giant Pfizer confirmed Monday that it wanted to take over Britain's AstraZeneca in a deal worth almost £60 billion.

Elsewhere, USD/CHF was trading at 0.8807, after falling as low as 0.8770 earlier.

The Australian dollar edged lower, with AUD/USD slipping 0.10% to 0.9258, while NZD/USD was down 0.54% to 0.8533. The Canadian dollar was slightly higher, with USD/CAD dipping 0.10% to 1.1026.

The US Dollar Index, which tracks the performance of the greenback versus a basket of six other major currencies, was at 79.82, up from lows of 79.61.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.